Nano-X Imaging Ltd. (NNOX) stock soared 62.93% at $67.34 in premarket trading hours on the last check Thursday. The stock of NNOX lost -0.29% to complete the last trading session at $41.33.
Nano-X Imaging Ltd (NNOX), an innovative medical imaging technology company which aims for mass deployment of cost reduced imaging systems, notified that its single-source Nanox. ARC digital x-ray technology has been given 510(k) Approval from the FDA, after which NNOX stock surged substantially. NANO-X is also expected to put forward another application for its multi-source Nanox Arcand the NanoxCloud, this year. If approved, the multisource NanoX ARC will be commercialized and sold globally.
“Obtaining 510(k) clearance from the FDA for our single-source Nanox.ARC digital x-ray is a significant step forward along our US regulatory pathway,” Concluded Ran Poliakine, CEO Nanox.
NNOX Distinctive Competency Over Its Peers
NNOX, founded by Ran Poliakine, is an Israel based corporation manufacturing a commercial-grade digital X-ray source which will be immensely significant for improved affordable medical imaging.
Nanoxplans for its unique technology to decrease the costs of medical imaging systems and aims for partnerships with several healthcare organizations for low cost, and an early detection medical imaging service. NNOX stock has aimed to finalize a minimum distribution of 15,000 Nanox ARC systems by the end of 2024.
NANO-X imaging has invested in a very lucrative market of Medical imaging especially amongst the time of a pandemic. NNOX stock has pioneered affordable quality medical imaging and approval by FDA may prove to be extremely significant in further diversifying their income stream and providing income stability as well as a financial surplus, with the company keen on producing results.